Is that it, then, for blockbuster drugs?
D000991:Antithrombins / Q000009:adverse effects / Q000627:therapeutic use; D001384:Azetidines / Q000009:adverse effects / Q000627:therapeutic use; D001596:Benzylamines; D017277:Drug Approval; D004345:Drug Industry; D014481:United States; D014486:United States Food and Drug Administration
D000991:Antithrombins; D001384:Azetidines; D001596:Benzylamines; C426686:ximelagatran